Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 22 | 2024 | 384 | 3.990 |
Why?
|
| Caenorhabditis elegans Proteins | 16 | 2024 | 396 | 3.180 |
Why?
|
| Caenorhabditis elegans | 17 | 2024 | 617 | 2.710 |
Why?
|
| RNA | 12 | 2024 | 404 | 2.140 |
Why?
|
| 3' Untranslated Regions | 8 | 2021 | 84 | 1.490 |
Why?
|
| Gene Expression Regulation, Developmental | 10 | 2021 | 630 | 1.160 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 1539 | 1.140 |
Why?
|
| Embryonic Development | 4 | 2021 | 136 | 1.110 |
Why?
|
| Carrier Proteins | 5 | 2017 | 710 | 1.020 |
Why?
|
| RNA, Messenger | 10 | 2021 | 1470 | 1.010 |
Why?
|
| RNA, Catalytic | 6 | 2002 | 18 | 0.810 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2013 | 10 | 0.800 |
Why?
|
| RNA, Helminth | 3 | 2015 | 46 | 0.770 |
Why?
|
| Animals | 32 | 2024 | 19614 | 0.680 |
Why?
|
| Oogenesis | 4 | 2013 | 45 | 0.680 |
Why?
|
| Gene Editing | 1 | 2024 | 289 | 0.670 |
Why?
|
| Proteins | 5 | 2017 | 742 | 0.630 |
Why?
|
| Nucleic Acid Conformation | 7 | 2013 | 231 | 0.620 |
Why?
|
| Binding Sites | 11 | 2024 | 875 | 0.620 |
Why?
|
| Protein Binding | 13 | 2024 | 1550 | 0.600 |
Why?
|
| Electrophoretic Mobility Shift Assay | 5 | 2010 | 64 | 0.550 |
Why?
|
| Conserved Sequence | 2 | 2014 | 171 | 0.550 |
Why?
|
| Alternative Splicing | 3 | 2013 | 120 | 0.540 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2013 | 12 | 0.530 |
Why?
|
| Base Sequence | 11 | 2014 | 1312 | 0.510 |
Why?
|
| RNA Stability | 2 | 2013 | 93 | 0.500 |
Why?
|
| Stem Cells | 2 | 2014 | 257 | 0.480 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 421 | 0.480 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 44 | 0.470 |
Why?
|
| Protein Biosynthesis | 3 | 2013 | 293 | 0.470 |
Why?
|
| Oleic Acid | 1 | 2014 | 21 | 0.470 |
Why?
|
| Cell Differentiation | 5 | 2015 | 1295 | 0.460 |
Why?
|
| Publishing | 1 | 2015 | 89 | 0.450 |
Why?
|
| Zinc Fingers | 4 | 2024 | 95 | 0.440 |
Why?
|
| Oligodendroglia | 2 | 2011 | 33 | 0.440 |
Why?
|
| RNA, Messenger, Stored | 2 | 2016 | 5 | 0.440 |
Why?
|
| RNA Editing | 1 | 2013 | 21 | 0.430 |
Why?
|
| Adenosine | 3 | 2003 | 70 | 0.430 |
Why?
|
| Eukaryota | 1 | 2013 | 29 | 0.430 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2012 | 21 | 0.410 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 72 | 0.410 |
Why?
|
| Oocytes | 1 | 2013 | 191 | 0.390 |
Why?
|
| RNA Interference | 4 | 2016 | 591 | 0.390 |
Why?
|
| Germ Cells | 4 | 2021 | 97 | 0.390 |
Why?
|
| Staining and Labeling | 1 | 2012 | 124 | 0.370 |
Why?
|
| Oligonucleotide Probes | 1 | 2010 | 43 | 0.370 |
Why?
|
| Nucleotides | 2 | 2001 | 42 | 0.360 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 195 | 0.350 |
Why?
|
| Oligonucleotides | 1 | 2012 | 208 | 0.340 |
Why?
|
| Totipotent Stem Cells | 1 | 2009 | 4 | 0.340 |
Why?
|
| Aptamers, Nucleotide | 1 | 2009 | 18 | 0.340 |
Why?
|
| Nucleic Acids | 1 | 2010 | 50 | 0.340 |
Why?
|
| Nematoda | 1 | 2010 | 34 | 0.340 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 1128 | 0.340 |
Why?
|
| Protein Structure, Tertiary | 6 | 2015 | 663 | 0.320 |
Why?
|
| Myelin Sheath | 1 | 2008 | 35 | 0.300 |
Why?
|
| DNA | 1 | 2012 | 793 | 0.280 |
Why?
|
| Fluorescence Polarization | 3 | 2014 | 32 | 0.270 |
Why?
|
| Drosophila Proteins | 2 | 2014 | 681 | 0.260 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 1977 | 0.260 |
Why?
|
| Mutation | 5 | 2024 | 2427 | 0.250 |
Why?
|
| Myelin Basic Protein | 1 | 2004 | 23 | 0.240 |
Why?
|
| Mice | 8 | 2014 | 10258 | 0.230 |
Why?
|
| Chromosome Deletion | 1 | 2024 | 41 | 0.220 |
Why?
|
| Cytidine | 1 | 2003 | 11 | 0.210 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 2 | 2013 | 5 | 0.200 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 376 | 0.200 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 482 | 0.190 |
Why?
|
| Crystallography, X-Ray | 4 | 2015 | 422 | 0.190 |
Why?
|
| Exons | 2 | 2013 | 193 | 0.190 |
Why?
|
| Fertility | 1 | 2021 | 85 | 0.190 |
Why?
|
| Untranslated Regions | 2 | 2012 | 3 | 0.180 |
Why?
|
| Kinetics | 3 | 2014 | 735 | 0.180 |
Why?
|
| Phenotype | 1 | 2024 | 1156 | 0.170 |
Why?
|
| Brain | 1 | 2008 | 1488 | 0.170 |
Why?
|
| Models, Molecular | 6 | 2024 | 1125 | 0.170 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1370 | 0.170 |
Why?
|
| Nucleotide Mapping | 1 | 1999 | 2 | 0.170 |
Why?
|
| Hermaphroditic Organisms | 1 | 2018 | 3 | 0.160 |
Why?
|
| Models, Biological | 3 | 2010 | 1139 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 292 | 0.160 |
Why?
|
| Cytoplasm | 2 | 2017 | 273 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2018 | 1456 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 182 | 0.140 |
Why?
|
| Consensus Sequence | 2 | 2008 | 28 | 0.140 |
Why?
|
| Mice, Quaking | 2 | 2008 | 3 | 0.140 |
Why?
|
| Body Patterning | 2 | 2008 | 85 | 0.140 |
Why?
|
| Uridine Monophosphate | 1 | 2016 | 8 | 0.140 |
Why?
|
| Fluorenes | 1 | 2016 | 13 | 0.140 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2014 | 111 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2016 | 59 | 0.130 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 281 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 88 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 853 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 697 | 0.120 |
Why?
|
| Substrate Specificity | 3 | 2015 | 321 | 0.120 |
Why?
|
| Polyadenylation | 1 | 2015 | 44 | 0.120 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2014 | 9 | 0.120 |
Why?
|
| Allosteric Site | 1 | 2014 | 31 | 0.120 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 81 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 695 | 0.120 |
Why?
|
| DNA, Single-Stranded | 1 | 2015 | 100 | 0.110 |
Why?
|
| Binding, Competitive | 3 | 2010 | 102 | 0.110 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 152 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 67 | 0.110 |
Why?
|
| Female | 5 | 2024 | 30827 | 0.110 |
Why?
|
| RNA Isoforms | 1 | 2013 | 3 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2016 | 314 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 115 | 0.110 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 14 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 22 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 71 | 0.100 |
Why?
|
| Spliceosomes | 1 | 2013 | 41 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2024 | 1582 | 0.100 |
Why?
|
| Humans | 10 | 2024 | 59326 | 0.100 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2012 | 12 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 96 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2011 | 16 | 0.100 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2011 | 28 | 0.100 |
Why?
|
| Computational Biology | 2 | 2010 | 325 | 0.090 |
Why?
|
| Ribonucleotides | 2 | 2002 | 15 | 0.090 |
Why?
|
| Catalysis | 2 | 2001 | 154 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 83 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 759 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2011 | 290 | 0.090 |
Why?
|
| Biolistics | 1 | 2009 | 4 | 0.090 |
Why?
|
| Dimerization | 2 | 2015 | 146 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 73 | 0.080 |
Why?
|
| Qa-SNARE Proteins | 1 | 2009 | 18 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 291 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 139 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2009 | 166 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2011 | 379 | 0.080 |
Why?
|
| Algorithms | 1 | 2014 | 986 | 0.080 |
Why?
|
| Catalytic Domain | 2 | 2001 | 184 | 0.080 |
Why?
|
| Introns | 2 | 2000 | 106 | 0.080 |
Why?
|
| Vesicular Transport Proteins | 1 | 2009 | 103 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 396 | 0.080 |
Why?
|
| Calorimetry | 1 | 2008 | 41 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2018 | 253 | 0.070 |
Why?
|
| Cell Line | 2 | 2011 | 2014 | 0.070 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2008 | 37 | 0.070 |
Why?
|
| Axons | 1 | 2008 | 120 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 87 | 0.070 |
Why?
|
| Tristetraprolin | 1 | 2007 | 7 | 0.070 |
Why?
|
| Rats | 1 | 2011 | 1907 | 0.070 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 112 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 847 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2024 | 766 | 0.060 |
Why?
|
| Genes, Insect | 1 | 2006 | 89 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 418 | 0.060 |
Why?
|
| Genes, Helminth | 1 | 2003 | 53 | 0.060 |
Why?
|
| Protein Domains | 1 | 2024 | 141 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2017 | 861 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 52 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 255 | 0.050 |
Why?
|
| RNA, Satellite | 1 | 2001 | 1 | 0.050 |
Why?
|
| Base Pairing | 1 | 2002 | 36 | 0.050 |
Why?
|
| Models, Chemical | 2 | 1999 | 133 | 0.050 |
Why?
|
| RNA, Fungal | 1 | 2001 | 36 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2002 | 129 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1093 | 0.050 |
Why?
|
| Organophosphates | 1 | 2001 | 16 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2003 | 377 | 0.050 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2000 | 2 | 0.040 |
Why?
|
| Phospholipase D | 1 | 2000 | 6 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2000 | 22 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2008 | 2890 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 2000 | 32 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 133 | 0.040 |
Why?
|
| Guanosine | 1 | 1999 | 10 | 0.040 |
Why?
|
| Phosphorus | 1 | 1999 | 17 | 0.040 |
Why?
|
| Thionucleotides | 1 | 1999 | 38 | 0.040 |
Why?
|
| Tetrahymena | 1 | 1998 | 7 | 0.040 |
Why?
|
| RNA, Protozoan | 1 | 1998 | 9 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2000 | 161 | 0.040 |
Why?
|
| Pyrimidines | 1 | 1999 | 123 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2000 | 367 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 45 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 150 | 0.040 |
Why?
|
| Xenopus | 1 | 2017 | 54 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2103 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 125 | 0.030 |
Why?
|
| Sofosbuvir | 1 | 2016 | 18 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 276 | 0.030 |
Why?
|
| Mesoderm | 1 | 2015 | 83 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 287 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2016 | 140 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 160 | 0.030 |
Why?
|
| Zinc | 1 | 2015 | 90 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 644 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 249 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 843 | 0.030 |
Why?
|
| Male | 2 | 2018 | 27509 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 58 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 116 | 0.020 |
Why?
|
| Genome | 1 | 2013 | 253 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 74 | 0.020 |
Why?
|
| Software | 1 | 2013 | 367 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2009 | 105 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 190 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3567 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 522 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 194 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 619 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1549 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 529 | 0.010 |
Why?
|
| Neurospora crassa | 1 | 2001 | 3 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2000 | 9 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 131 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 353 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 298 | 0.010 |
Why?
|